Date | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) |
---|
CEO | Mr. Andrew Simpson |
IPO Date | June 16, 2022 |
Location | United States |
Headquarters | 550 Reserve Street |
Employees | 15 |
Sector | Health Care |
Industries |
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
Past 5 years
USD 1.67
USD 8.87
USD 3.36
USD 1.05
USD 3.98
USD 4.66
StockViz Staff
January 15, 2025
Any question? Send us an email